相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Life histories of myeloproliferative neoplasms inferred from phylogenies
Nicholas Williams et al.
NATURE (2022)
PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation
Prasidda Khadka et al.
NATURE COMMUNICATIONS (2022)
PPM1D mutations appear in complete remission after exposure to chemotherapy without predicting emerging AML relapse
Adil S. A. Al Hinai et al.
LEUKEMIA (2021)
Systematic characterization of mutations altering protein degradation in human cancers
Collin Tokheim et al.
MOLECULAR CELL (2021)
The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms
Jason R. Schwartz et al.
NATURE COMMUNICATIONS (2021)
Impact of PPM1D mutations in patients with myelodysplastic syndrome and deletion of chromosome 5q
Victoria Panagiota et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
High Expression of PPM1D Induces Tumors Phenotypically Similar to TP53 Loss-of-Function Mutations in Mice
Jelena Milosevic et al.
CANCERS (2021)
Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a
Maria Chiara Fontana et al.
BIOMEDICINES (2021)
The Cancer Therapy-Related Clonal Hematopoiesis Driver Gene Ppm1d Promotes Inflammation and Non-Ischemic Heart Failure in Mice
Yoshimitsu Yura et al.
CIRCULATION RESEARCH (2021)
Inhibition of the DNA damage response phosphatase PPM1D reprograms neutrophils to enhance anti-tumor immune responses
Burhan Uyanik et al.
NATURE COMMUNICATIONS (2021)
From Favorable Histology to Relapse: The Clonal Evolution of a Wilms Tumor
Jason Saliba et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2020)
WIP1 dephosphorylation of p27Kip1 Serine 140 destabilizes p27Kip1 and reverses anti-proliferative effects of ATM phosphorylation
Byung-Kwon Choi et al.
CELL CYCLE (2020)
Wip1 regulates Smad4 phosphorylation and inhibits TGF-β signaling
Dong-Seok Park et al.
EMBO REPORTS (2020)
PPM1D Functions as Oncogene and is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma
Ke Li et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
The role of PPM1D in cancer and advances in studies of its inhibitors
Wenhong Deng et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Targeting Mutant PPM1D Sensitizes Diffuse Intrinsic Pontine Glioma Cells to the PARP Inhibitor Olaparib
Zhaohui Wang et al.
MOLECULAR CANCER RESEARCH (2020)
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
Kelly L. Bolton et al.
NATURE GENETICS (2020)
Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics
Kiyomi Morita et al.
NATURE COMMUNICATIONS (2020)
Truncated PPM1D Prevents Apoptosis in the Murine Thymus and Promotes Ionizing Radiation-Induced Lymphoma
Andra S. Martinikova et al.
CELLS (2020)
PPM1D Knockdown Suppresses Cell Proliferation, Promotes Cell Apoptosis, and Activates p38 MAPK/p53 Signaling Pathway in Acute Myeloid Leukemia
Bin Li et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2020)
Cell Model Passportsa hub for clinical, genetic and functional datasets of preclinical cancer models
Dieudonne van der Meer et al.
NUCLEIC ACIDS RESEARCH (2019)
Detectible mosaic truncating PPM1D mutations, age and breast cancer risk
Mitchell J. Machiela et al.
JOURNAL OF HUMAN GENETICS (2019)
Spinal cord high-grade infiltrating gliomas in adults: clinico-pathological and molecular evaluation
Mohammed Ali Alvi et al.
MODERN PATHOLOGY (2019)
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas
Lawrence A. Donehower et al.
CELL REPORTS (2019)
Truncated PPM1D impairs stem cell response to genotoxic stress and promotes growth of APC-deficient tumors in the mouse colon
Monika Burocziova et al.
CELL DEATH & DISEASE (2019)
PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma
Nathan R. Fons et al.
NATURE COMMUNICATIONS (2019)
WIP1 Promotes Homologous Recombination and Modulates Sensitivity to PARP Inhibitors
Kamila Burdova et al.
CELLS (2019)
Mutant p53 as a guardian of the cancer cell
Fiamma Mantovani et al.
CELL DEATH AND DIFFERENTIATION (2019)
Age-related remodelling of oesophageal epithelia by mutated cancer drivers
Akira Yokoyama et al.
NATURE (2019)
p53 modifications: exquisite decorations of the powerful guardian
Yanqing Liu et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2019)
PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells
Josephine D. Kahn et al.
BLOOD (2018)
Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential
Terrence N. Wong et al.
NATURE COMMUNICATIONS (2018)
Wip1/ knockout inhibits neurogenesis by affecting the Wnt/β-catenin signaling pathway in focal cerebral ischemia in mice
Cai-Wei Qiu et al.
EXPERIMENTAL NEUROLOGY (2018)
Alcohol and endogenous aldehydes damage chromosomes and mutate stem cells
Juan I. Garaycoechea et al.
NATURE (2018)
PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy
Joanne Hsu et al.
CELL STEM CELL (2018)
Classification and Personalized Prognosis in Myeloproliferative Neoplasms
J. Grinfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Clinical significance of Wip1 overexpression and its association with the p38MAPK/p53/p16 pathway in NSCLC
Shize Yang et al.
MOLECULAR MEDICINE REPORTS (2017)
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma
Christopher J. Gibson et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study
Nancy K. Gillis et al.
LANCET ONCOLOGY (2017)
Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study
Koichi Takahashi et al.
LANCET ONCOLOGY (2017)
Wip1 regulates SKOV3 cell apoptosis through the p38 MAPK signaling pathway
Yanping Feng et al.
MOLECULAR MEDICINE REPORTS (2017)
Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation
R. C. Lindsley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
S. Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Wip1 gene silencing enhances the chemosensitivity of human colon cancer cells
Zhong-Sheng Xia et al.
ONCOLOGY LETTERS (2017)
Wip1 is associated with tumorigenity and metastasis through MMP-2 in human intrahepatic cholangiocarcinoma
Sulai Liu et al.
ONCOTARGET (2017)
Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes
Catherine C. Coombs et al.
CELL STEM CELL (2017)
Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly
Florian Zink et al.
BLOOD (2017)
PPM1D exerts its oncogenic properties in human pancreatic cancer through multiple mechanisms
Bo Wu et al.
APOPTOSIS (2016)
PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations
Paul D. P. Pharoah et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
WIP1 modulates responsiveness to Sonic Hedgehog signaling in neuronal precursor cells and medulloblastoma
J. Wen et al.
ONCOGENE (2016)
Inhibition of WIP1 phosphatase sensitizes breast cancer cells to genotoxic stress and to MDM2 antagonist nutlin-3
Sona Pechackova et al.
ONCOTARGET (2016)
p53 in the DNA-Damage-Repair Process
Ashley B. Williams et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations
Paul D. P. Pharoah et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
PPM1D regulates p21 expression via dephoshporylation at serine 123
Ruibing Cao et al.
CELL CYCLE (2015)
DNA damage-induced regulatory interplay between DAXX, p53, ATM kinase and Wip1 phosphatase
Jan Brazina et al.
CELL CYCLE (2015)
Modulation of LSD1 phosphorylation by CK2/WIP1 regulates RNF168-dependent 53BP1 recruitment in response to DNA damage
Bin Peng et al.
NUCLEIC ACIDS RESEARCH (2015)
WIP1 stimulates migration and invasion of salivary adenoid cystic carcinoma by inducing MMP-9 and VEGF-C
Ya-ling Tang et al.
ONCOTARGET (2015)
The WIP1 oncogene promotes progression and invasion of aggressive medulloblastoma variants
M. C. Buss et al.
ONCOGENE (2015)
Expression of Wip1 in Kidney Carcinoma and its Correlation with Tumor Metastasis and Clinical Significance
G. G. Sun et al.
PATHOLOGY & ONCOLOGY RESEARCH (2015)
Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas
Liwei Zhang et al.
NATURE GENETICS (2014)
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Giulio Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters
Jayne Loughery et al.
NUCLEIC ACIDS RESEARCH (2014)
Proto-oncogene Wip1, a member of a new family of proliferative genes in NSCLC and its clinical significance
Zhanzhao Fu et al.
TUMOR BIOLOGY (2014)
WIP1 regulates the proliferation and invasion of nasopharyngeal carcinoma in vitro
Yongquan Zhang et al.
TUMOR BIOLOGY (2014)
PPM1D silencing by RNA interference inhibits the proliferation of lung cancer cells
Chen Zhang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2014)
PPM1D is a prognostic marker and therapeutic target in colorectal cancer
Tian-Shu Peng et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2014)
Genetic variants and mutations of PPM1D control the response to DNA damage
Crissy Dudgeon et al.
CELL CYCLE (2013)
Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint
Petra Kleiblova et al.
JOURNAL OF CELL BIOLOGY (2013)
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer
Elise Ruark et al.
NATURE (2013)
Knockdown of Protein Phosphatase Magnesium-dependent 1 (PPM1D) through Lentivirus-mediated RNA Silencing Inhibits Colorectal Carcinoma Cell Proliferation
Hongzhuan Yin et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2013)
Regulation of the Wip1 phosphatase and its effects on the stress response
Julie Lowe et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2012)
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Paul A. Northcott et al.
NATURE (2012)
Wip1 Directly Dephosphorylates Y-H2AX and Attenuates the DNA Damage Response
Hyukjin Cha et al.
CANCER RESEARCH (2010)
Dephosphorylation of γH2AX by WIP1 An important homeostatic regulatory event in DNA repair and cell cycle control
Sung-Hwan Moon et al.
CELL CYCLE (2010)
The oncogenic phosphatase WIP1 negatively regulates nucleotide excision repair
Thuy-Ai Nguyen et al.
DNA REPAIR (2010)
Nuclear Factor-κB (NF-κB) Is a Novel Positive Transcriptional Regulator of the Oncogenic Wip1 Phosphatase
Julie M. Lowe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
MRE11-RAD50-NBS1 Complex Dictates DNA Repair Independent of H2AX
Jingsong Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization study
Maryou B. Lambros et al.
MODERN PATHOLOGY (2010)
Downregulation of Wip-1 phosphatase expression in MCF-7 breast cancer cells enhances doxorubicin-induced apoptosis through p53-mediated transcriptional activation of Bax
Weihong Kong et al.
CANCER BIOLOGY & THERAPY (2009)
PPM1D Is a Potential Therapeutic Target in Ovarian Clear Cell Carcinomas
David S. P. Tan et al.
CLINICAL CANCER RESEARCH (2009)
WIP1 phosphatase is a negative regulator of NF-κB signalling
Joanne Chew et al.
NATURE CELL BIOLOGY (2009)
The wip1 phosphatase PPM1D dephosphorylates SQ/TQ motifs in checkpoint substrates phosphorylated by PI3K-like kinases
Hiroshi Yamaguchi et al.
BIOCHEMISTRY (2007)
The Wip1 phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop
Xiongbin Lu et al.
CANCER CELL (2007)
Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers
Eunsil Yu et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Wip1 phosphatase modulates ATM-dependent signaling pathways
Sathyavageeswaran Shreeram et al.
MOLECULAR CELL (2006)
Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase
H. Fujimoto et al.
CELL DEATH AND DIFFERENTIATION (2006)
Comprehensive genomic analysis of desmoplastic medulloblastomas:: identification of novel amplified genes and separate evaluation of the different histological components
A Ehrbrecht et al.
JOURNAL OF PATHOLOGY (2006)
The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours
J Rauta et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints
XB Lu et al.
GENES & DEVELOPMENT (2005)
Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16Ink4a-p19Arf pathway
DV Bulavin et al.
NATURE GENETICS (2004)
The p53-induced oncogenic phosphatase PPM1D interacts with uracil DNA glycosylase and suppresses base excision repair
XB Lu et al.
MOLECULAR CELL (2004)
Control of apoptosis by p53
JS Fridman et al.
ONCOGENE (2003)
Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity
DV Bulavin et al.
NATURE GENETICS (2002)
Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23
J Li et al.
NATURE GENETICS (2002)
p53 regulation of DNA excision repair pathways
ML Smith et al.
MUTAGENESIS (2002)
Chk2 activation dependence on Nbs1 after DNA damage
G Buscemi et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
The structure and expression of the murine wildtype p53-induced phosphatase 1 (Wip1) gene
J Choi et al.
GENOMICS (2000)
DNA damage-induced activation of p53 by the checkpoint kinase Chk2
A Hirao et al.
SCIENCE (2000)
分享论文
